Peter Ernst focuses his practice on mergers and acquisitions, private equity, and general corporate advisory work.
Peter represents private equity funds and their portfolio companies in mergers and acquisitions, growth equity investments, and other strategic transactions.
Experience
Peter’s experience includes representing:
Empyrean Solutions in its significant investment from Hg*
Serent Capital in its significant investment in Casino Cash Trac*
Pulmokine in its acquisition by XOMA Royalty*
BV Investment partners in its acquisition of Balance Partners*
Sunstone Partners in its growth investment in Accuhealth*
*Matter handled prior to joining Latham
Thought Leadership
“Disparities in Exposure to Television Advertising of Sugar Sweetened and Non-Nutritive Sweetened Beverages Among U.S. Adults and Teens, 2007-2013,” co-author, Preventative Medicine, September 2021
Qualifications
Bar Qualification
Massachusetts
Education
JD, Harvard Law School, 2023
BS in Policy Analysis and Management, Cornell University, 2019 with distinction
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.